Introduction
Graves' disease (GD) is usually considered an autoimmune organ-specific disease, although this classification may be questioned in view of its extra-thyroidal manifestations, namely Graves' ophthalmopathy (GO), pretibial myxedema, and Graves' acropachy [1] [2] [3] [4] . The main pathogenic mechanism responsible for the thyroid features of the disease, namely hyperthyroidism and goiter, is the stimulation of thyroid hormone synthesis and secretion and of thyrocyte growth by autoantibodies directed against the thyroid-stimulating hormone (TSH) receptor (TSH-R), thereby mimicking the effects of TSH [1] . Thus, the TSH-R is universally regarded as a major autoantigen in GD. Nevertheless, in spite of the advancements in understanding the pathogenic mechanisms of GD, its ultimate cause remains elusive. The majority of investigators agree that GD is likely a multifactorial disease, due to a complex interplay of genetic and non-genetic factors that lead to the loss of immune tolerance to thyroid antigens and to the initiation of a sustained autoimmune reaction. Here we review the respective role of genetic and non-genetic factors in the etiology of GD, taking advantage of the great bulk of data generated especially over the last 30 years. rate of GD in monozygotic than in dizygotic twins. The concordance rate, although remarkable, is not extremely high (~17 to ~35 %) even in monozygotic twins, thus suggesting a low penetrance of the genes involved [5] [6] [7] .
A way to determine a genetic predisposition to a given disease is to perform family studies, where the occurrence of the disease is compared in relatives of index cases versus the general population. Early studies demonstrated a high prevalence of GD and of other thyroid abnormalities in first-degree relatives of patients with GD or autoimmune thyroiditis (AT) [8] . In even earlier studies the presence of circulating thyroid autoantibodies against thyroglobulin (TgAb) and thyroperoxidase (TPOAb) was found in about half of siblings of patients [9] , thereby suggesting a dominant mode of inheritance. These observations were consistently confirmed in highly selected populations [10] [11] [12] [13] , although the results may be affected by ascertainment bias. In a segregation analysis with randomly ascertained probands, serum TgAb and/or TPOAb were detectable only in 25 % of the offspring of positive parents compared with 14 % in the offspring of negative parents [14] . These findings suggested a multigenic model of inheritance with less than 100 % penetrance for the antibody trait. As a matter of fact, with the exception of early studies, the prevalence of GD was found to be relatively low in siblings of patients, who apparently are more prone to carry subclinical abnormalities of thyroid function [15] [16] [17] [18] . Villanueva et al. [19] found that 36 % of GD patients with GO have a family history of either GD or TA, which in 23 % of the cases was observed in first degree relatives. Hemmiki et al. [20] found a 3.6 % prevalence of GD in the offspring of affected subjects. TA is observed frequently in siblings of probands with GD as well as the contrary [16, 17, 19] . These observations suggest not only that the two diseases probably share some susceptibility genes, but also that the full expression of the phenotype depends on other, more specific genes, and/or on non-genetic factors.
Overall, the data from twin and family studies indicate a complex multigenic pattern of inheritance. Some of the components of the phenotype, such as circulating TgAb and TPOAb, may be inherited in a dominant fashion with high penetrance, although these genetic determinants do not appear sufficient for the full expression of the disease. Thus, other genes must clearly be involved, which is in line with the complexity of the inheritance mode observed. In addition, it seems clear from epidemiological and experimental data that environmental factors play an important role, most likely by modulating the effect of an inherited predisposition.
Genes involved in the genetic predisposition to GD A large number of genes have been studied as possible candidates for predisposing to GD [21] [22] [23] [24] [25] [26] . In agreement with twin and family studies, their penetrance seems to be relatively low, again confirming a complex model of inheritance as well as a remarkable role of non-genetic factors. A major problem related to genes predisposing to GD is due to the countless number of studies performed especially in the past few years, with findings that are often conflicting, possibly reflecting racial and environmental differences, and that render the interpretation of the data rather difficult.
Early data on genes predisposing to GD derive from association studies, whereas studies in the past 10-15 years have been performed using linkage analysis or a wide genome screening, either with microsatellites or single-nucleotide polymorphisms (SNPs). The major genes predisposing to GD are listed in Table 1 and discussed below.
HLA
The HLA complex is located on the short arm of chromosome 6 and contains sequences encoding genes involved in the regulation of the immune response [27] . HLA genes are classified into three major classes: (1) Class I, including histocompatibility genes expressed on the surface of most cells (HLA-A, HLA-B, and HLA-C); (2) Class II, including histocompatibility genes expressed exclusively on leukocytes and immune competent cells (HLA-DR); and (3) Class III, including a heterogeneous group of genes encoding molecules that are involved in the immune response and others that are not clearly related with immunity. Most HLA genes are highly polymorphic, thereby making them excellent candidates for disease susceptibility. Early studies suggested an association of GD with HLA-B8, with a relative risk of 3.9 in patients of Caucasian descent [28, 29] . Later, HLA-DR3 (HLA-DRB1*03) was shown to increase the risk to a greater extent than HLA-B8 [30] , because of which it was considered the true determinant of the disease, also in view of the fact that it is in linkage disequilibrium with B8. HLA-DQA1*0501 was found to confer a relatively high risk within DR3 itself in the white population [31] . This allele is in linkage disequilibrium with both B8 and DR3 and gives a relative risk of 3-4 for GD in Caucasians. Sequencing of the DRβ-1 chain of HLA-DR3 led to the identification of Arg74 as the critical amino acid conferring a genetic susceptibility to GD [32] . Different haplotypes seem to be involved in ethnic groups other than Caucasians: DQ3 in patients of African descent and Bw46 in those of Asian descent [33, 34] , although the available data are limited and not always reproducible [27, 35] . Overall, HLA genes seem to confer a relatively low risk, even with alleles that have a quite high prevalence in the general population. As a consequence, linkage studies found negative results when the HLA region was examined using different polymorphisms at the same locus [36] . The HLA locus seems to explain only a small proportion of the total genetic predisposition and most likely HLA is neither the major nor the only determinant, although it represents an established risk factor [27] .
CD40
CD40 is a member of the tumor necrosis factor receptor family expressed in B cells as well as in other antigen presenting cells [37] . CD40 is involved in B cell activation and proliferation, antibody secretion, immunoglobulin class switching, affinity maturation, and generation of memory cells [37] . Linkage studies have shown an association of the CD40 gene with GD [21] [22] [23] [24] [25] [26] . Sequencing of the gene led to the identification of a C/T polymorphism at the 5′ untranslated region, which was strongly associated with GD [38] . This polymorphism influences the translational efficiency of the gene and may have functional consequences in the protein [38] .
CTLA-4
CTLA-4 is a T lymphocyte surface protein with a major role in the down-regulation of the immune response [39] . Several studies have shown that CTLA-4 is linked to GD, AT, and also to the production of TgAb and TPOAb [40] [41] [42] [43] [44] . A number of variants of the gene have been implicated in GD, of which a polymorphism at position 60 is the most suitable candidate [43] . The functional relevance of this polymorphism is believed to be due to a reduced expression of the mRNA encoding the soluble form of the molecule. However, these data were not confirmed [44] . Thus, although CTLA-4 seems to be a genetic determinant of GD, the causative variant remains to be identified, and it is rather possible that a haplotype consisting of more than one variant is responsible for the association.
PTPN22
PTPN22 is a powerful inhibitor of T cell activation [45] . A SNP at codon 620, which is associated with other autoimmune diseases, was found both in GD and AT [46] ; ethnic differences significantly influenced this association [47] .
FCRL3
The FCRL gene family encodes a number of proteins involved in the control of B cell signaling [48] . Recent studies have shown an association of SNPs of FCRL3 with GD, in patients of Asian as well as of Caucasian descent [49, 50] , whereas FCRL5, which has also been investigated, seems to have a limited role [51] .
Thyroid autoantigens
Among thyroid autoantigens, Tg and the TSH-R have been investigated extensively. Tg is the precursor of thyroid hormones and a major autoantigen involved in the pathogenesis of AT and possibly contributing the pathogenesis of GO [52] . Wide genome screenings have shown a linkage between a locus on chromosome 8q24, where the Tg gene is located, and autoimmune thyroid diseases (AITD) [53] . Sequence analysis of the Tg gene has shown various missense SNPs, suggesting that amino acid variants may contribute the pathogenesis of AITD, including GD [54] . Recent studies have suggested a genetic/epigenetic mechanism by which a SNP variant of the Tg promoter predisposes to AITD, by an altered interaction with interferon regulatory factor-1 [55] .
In spite of its central role in the pathogenesis of GD, the role of the gene encoding the TSH-R appeared to be limited until recent studies. Thus, although three missense SNPs were found to be associated with GD, these associations were not always confirmed [21] [22] [23] [24] [25] [26] . However, based on the hypothesis that epigenetic modifications induced by environmental influences of cytokines may reveal the functionality of GD-associated SNPs, Stefan et al. [56] recently provided evidence for a major role of the TSH-R. They analyzed genome-wide histone H3 lysine 4 methylation and gene expression in thyroid cells induced by interferon-α (IFNα), a key cytokine during viral infections, and overlapped them with known GD-associated SNPs.
They mapped an open region of chromatin that overlaps two GD-associated SNPs in intron 1 of the TSH-R gene and showed that this region serves as a regulatory element via binding of the transcriptional repressor promyelocytic leukemia zinc finger protein (PLZF) at the rs12101261 site. Thus, repression by PLZF depended on the rs12101261 disease susceptibility allele and was increased by IFNα. The intrathymic expression of the TSH-R was decreased in individuals being homozygous for the rs12101261 disease-associated genotype compared with those carrying the disease-protective allele. Thus, they provided evidence for a genetic-epigenetic interaction involving a noncoding SNP of the TSH-R gene that regulates thymic TSH-R gene expression and facilitates escape of TSH-R-reactive T cells from central tolerance, thereby possibly triggering GD [56] .
Other genes
Several other genes involved in the immune response in general, and in thyroid autoimmunity in particular, have been studied over the years. The immunoglobulin genes were investigated extensively, raising, however, only conflicting results [21] [22] [23] [24] [25] [26] . Other candidate genes include those encoding interleukin-1 (IL-1), IL-1 receptor antagonist, interleukin 2 (IL-2) receptor alpha, tumor necrosis factor receptor-2, and interferon-γ (INF-γ), most of which showed no significant associations with GD [21] [22] [23] [24] [25] [26] . Recently, tumor necrosis factor α (TNFα) and interleukin 6 (IL6) [57] , as well as several other genes especially in young GD patients [58] , have also been implicated. Additional loci have been linked in families with GD, including one on chromosome 14q31, one on chromosome 20, one on chromosome Xq21-22 [21] [22] [23] [24] [25] [26] , and more recently one on chromosome 10q [59] .
Non-genetic factors
The relative low penetrance in twins and first-degree relatives of patients with GD suggests that non-genetic factors must play a major role in inducing the disease in genetically susceptible individuals. Several studies have shown that various agents may in fact contribute the development of the disease. The various factors involved in the etiology of GD are discussed below and listed in Table 2 .
Iodine A large body of epidemiological data suggest that the dietary iodine supply play a major role in eliciting the occurrence of GD in genetically predisposed individuals. Overall, GD is a relatively prevalent disorder, being the most frequent cause of thyrotoxicosis, at least in iodine-sufficient countries [60] .
Although several studies have tried to determine the exact frequency of GD in the general population, comparison of surveys is quite difficult due to the use of different criteria in population sampling, to ethnic differences, and to the fact that diagnostic tools have changed over the years. A large survey performed in the 1970s in the Unites States determined a prevalence of 0.4 % [61] . Similar findings, namely a prevalence of 0.6 %, were obtained by population screening of an iodine-deficient village of Italy [62, 63] .
The Whickham survey, performed in the United Kingdom, estimated a prevalence ranging from 1.1 to 1.6 % for thyrotoxicosis of all causes, of which GD was likely the most frequent one [64] . Recent studies performed in Sweden have estimated an incidence of GD ranging between ~21 and ~25 cases/100,000 per year [65, 66] . Finally, a metaanalysis of the various studies has come to the conclusion that the overall prevalence is about 1 %, thereby making GD one of the most common autoimmune disorders [67] .
As mentioned above, dietary iodine supply is a major factor in determining the frequency of GD [68] [69] [70] [71] [72] [73] [74] [75] . Abrupt iodine supplementation of previously iodine-deficient Tasmania was followed by a threefold increase in the incidence of hyperthyroidism in 3 years [68] . Although the increase reflected mainly iodine-induced thyrotoxicosis in patients with autonomously functioning nodules or goiters, it was also shown that the then called LATS (long acting thyroid stimulators, now known to be TRAb) were present in some cases of thyrotoxicosis in the early supplementation period, therefore, suggesting that to some extent hyperthyroidism was due to GD. After the Tasmanian report, outbreaks of iodine-induced thyrotoxicosis were reported in many countries following the implementation of iodine supplementation programs [69] [70] [71] [72] [73] [74] [75] . Thyrotoxicosis occurred primarily in older people with preexisting nodular goiter although in a study performed in Switzerland a mild and transient increase in the incidence of GD was noted after stepwise, full iodine supplementation (Fig. 1) [70] . Similar increases of thyrotoxicosis incidence were reported in other countries, namely Sweden (16.6/100,000) [71] , New Zealand (15/100,000) [72] , Britain (23/100,000) [73] , and Denmark [74] , in the last especially in younger age groups [75] . Population-based studies also showed a greater incidence of GD in iodine-sufficient areas, but also a higher frequency of nonautoimmune thyrotoxicosis in iodine-deficient areas. Thus, the comparison of two genetically similar populations that differed in iodine intake (iodine-sufficient Iceland vs. iodine-deficient East Jutland in Denmark) showed that the incidence of Graves' hyperthyroidism was slightly higher in the iodine-sufficient (20/100,000 inhabitants/ year) than in the iodine-deficient population (15/100,000/ year), but that the incidence of thyrotoxicosis of all causes was greater in the iodine-deficient (39/100,000/year vs. 23/100,000/year) population [60] . Overall, these observations lead to the clear-cut conclusion that fear of an increased incidence of GD should not prevent the implementation of iodine supplementation programs, but support a role of iodine as an environmental factor involved in the etiology of GD. In further support of iodine supplementation programs, it has to be kept in mind that iodine is not the sole cause of GD, but only one of the elements that concur in precipitating GD in genetically susceptible individuals. Thus, it is quite possible that only the latter develop GD as a consequence of iodine supplementation, whereas individuals that are not genetically susceptible to GD do not do so, which remains to be investigated. In addition, it is also possible that iodine precipitates overt hyperthyroidism in patients with a pre-existing, yet subclinical GD, in whom a mild hyperthyroidism is limited by iodine deficiency.
Infectious diseases
The possible role of infections in the pathogenesis of GD has been suggested both by experimental and epidemiologic data [76] . First, seasonal and geographic variations in the incidence of the disease have been reported [77, 78] , although seasonal variations have not been confirmed [79] . Likewise, the observation of higher birth rates in the autumn/winter period in patients with AITD, including GD, which had suggested an increased viral/bacterial exposure after birth possibly predisposing to AITD later in life, was not confirmed by a recent study [80] . Subjects that are more susceptible to infections, such as blood group nonsecretors, are apparently more frequently found among GD patients than in controls [81] , which may indirectly indicate that infectious pathogens may be involved in the etiology of GD, although a direct genetic predisposition linked to the secretor status could also explain these findings.
A recent viral infection has been reported in a relatively high percentage of patients with GD [76] . One of the mechanisms that may explain the association between infections and GD is molecular mimicry [76, 82] . The hypothesis is that a cross-reaction of microbial antigens with self-antigens may cause an immune response to autoantigens.
Yersinia enterocolitica has been thoroughly studied in GD after reports of an association with this thyroid disorder. Early studies showed a relatively high prevalence of circulating antibodies against Y. enterocolitica in GD and these antibodies were found to interact with thyroid structures [83] . In addition, a controlled study performed in Denmark showed that IgA and IgG antibodies against Yersinia not only are more frequent in GD patients than in case-controls, but also in twins with GD compared with their discordant twins [84] . Saturable binding sites for TSH that are recognized by TRAbs have been found in Yersinia [83] , and immunization of animals with Yersinia proteins led to the development of antibodies reacting with human thyrocytes and the TSH-R, although with low affinity and present only transiently in the circulation [85] . On the other hand, low-affinity binding sites for TSH were found also in other bacteria, including some species of Leishmania and Mycoplasma [76] and, in spite of these intriguing observations, thyroid autoimmunity does not develop in most patients with Yersinia infections [86] . Thus, the role of Yersinia infections as a precipitating factor of GD awaits confirmation. Serum antibodies against Helicobacter pylori were found in a greater proportion of pediatric patients with GD than in controls [87] , and recently an association between Cag-A positive strains of Helicobacter pylori has been reported in GD [88] . Both observations suggest a possible role of this microorganism, which, however, requires confirmation.
In theory, viruses could trigger autoimmunity via several mechanisms, namely interaction with autoantigens, expression of viral proteins on the surface of epithelial cells, aberrant induction of HLA antigens, and molecular mimicry [76] . In the late 1980s retroviral (HIV-1 glycosaminoglycan protein) sequences were found in thyroid cells and in peripheral mononuclear cells from patients with GD [89] . However, this finding was not confirmed by subsequent studies [90, 91] . Also human foamy virus antigens were found in the thyroid of patients with GD [92] , but again, more specific and sensitive techniques failed to identify foamy virus DNA and antiviral antibodies in the blood of affected subjects in additional studies [93, 94] . Another HIV-1 protein (Nef) was found to carry some homology with the human TSH-R, but sera from patients with GD failed to bind to the peptide bearing the highest degree of homology [95] . Another retroviral protein, p15E, was identified in the thyroid tissue of GD patients but not in control glands [96] . In this regard, it has to be considered that retroviral-like proteins, including p15E, are encoded by the normal human genome [97] . Thus, although their function is unclear, they may be expressed in many epithelial tissues under certain conditions, such as inflammation and may, therefore, modulate but not initiate the immune response. The presence of retroviral sequences or of retroviral proteins in the thyroid of GD patients may, therefore, represent a secondary rather than a causative phenomenon. Serum antibodies against another retroviral particle, namely HIAP-1, have been found in as many as 87.5 % of patients with GD compared with 10-15 % of controls [98] , but HIAP-1 particles were not detected in human T cells co-cultured with Graves' thyrocytes [91] .
A rather speculative hypothesis concerning infections is the so-called superantigens theory [76] . Superantigens are endogenous or exogenous proteins, such as microbial proteins, which are capable of stimulating a strong immune response through molecular interactions with nonvariant parts of the T cell receptor and HLA class II proteins. Through this mechanism, superantigens are in theory capable of stimulating the expansion of autoreactive T cells and, therefore, of driving an autoimmune response. A similar mechanism has been proposed for other autoimmune diseases such as rheumatoid arthritis. In vitro, superantigen stimulation of thyroid glands from patients with AITD was followed by the expression of HLA class II molecules on thyrocytes [99] . The interpretation was that in AITD superantigen-reactive T cells exist among thyroid infiltrating lymphocytes and that these lymphocytes may have been activated after exposure to extrinsic superantigens. Nevertheless, after this initial observation, the superantigens hypothesis was not pursued further and the possibility that superantigens are actually involved in the pathogenesis of GD remains only theoretical.
Another hypothesis is the so-called "hygiene hypothesis of autoimmunity", which implies that infections may protect from, rather than precipitate, autoimmune diseases, because exposure of the immune system to infective agents may somehow allow a better control of autoimmune responses [76] . In agreement with this hypothesis, improved living standards have been associated with decreased exposure to infections and increased risk of autoimmune diseases. A reduced prevalence of thyroid autoantibodies was reported in a population with lower economic standards [100] , which may suggest that the hygiene hypothesis may apply to the thyroid. Obviously, further studies are needed to investigate whether this hypothesis is correct.
In summary, although epidemiologic evidence indicates that infection may have an etiologic role in GD, a definitive identification of the etiologic organism(s) is still lacking as well as a reasonable explanation for microbes to precipitate or protect from the disorder.
Psychological stress
Psychological stress is associated with an increased secretion of the adrenocorticotropic hormone (ACTH) and of cortisol, which can in turn determine immune suppression, which can also be elicited by additional non-ACTH-related phenomena [101] . Recovery from such immune suppression, the so-called "immune rebound", can be associated with immune hyperactivity, which could in theory precipitate autoimmunity. A similar phenomenon was described following treatment of Cushing's syndrome [102] . Another example is the well-documented immune suppression of pregnancy, which can be followed in the post-partum period by new or recurrent onset of autoimmune disorders, including GD [103] . As a matter of fact, the possibility that psychological stress may be a precipitating factor in GD has been hypothesized as early as the very first description of the disease [104] , and the occurrence of stressful life events before the onset of GD is a long-lasting common impression among clinicians so much that by the end of the nineteenth century GD was considered the result of prolonged emotional disturbances. Cross-sectional questionnaire-based studies have shown an increased prevalence of stressful life events in the months preceding the onset of GD [105] [106] [107] [108] . However, some of the events (such as arguments with spouses and in the workplace) could have been due to the behavior of patients with a yet undetected hyperthyroidism, and, therefore, be a consequence rather than a cause of the disease. Nevertheless, other events, such as unemployment and financial difficulties, were largely independent of the patient's behavior. In certain studies in which patients were asked to rate the stressfulness of life events, patients with GD ranked such events more stressful than controls, suggesting that the perception of the events is different in hyperthyroid patients [105] [106] [107] [108] . Crosssectional population studies generated conflicting results. Thus, an increase in the prevalence of GD was recorded during World War II in Germany, but not during the civil unrest in Ireland or during the German occupation of Belgium, suggesting that the stressful events of personal life may be more important than "social stress" [105] [106] [107] [108] . On the other hand, chronic stress due to panic disorder was not associated with the occurrence of GD [109] .
Overall, limited though significant evidence indicates that psychological stress may contribute the etiology of GD, probably along with other predisposing and/or precipitating factors. Unfortunately, prospective studies addressing this issue are not available to date and the studies available, being all retrospective, carry a number of possible biases.
Gender
It is well known that AITD, including GD, are much more frequent in women than in men, with a female-to-male ratio ranging from 5 to 10 at any age, although the difference seems to be smaller during childhood [110] [111] [112] . The reasons for this disproportionate prevalence are unknown, but both genetic and non-genetic factors have been implicated. Several studies indicate a somehow stronger immune system in women [113] . In general, autoimmune phenomena and diseases are more frequent in women and a large body of evidence indicate the existence of sexual dimorphism in normal and abnormal immune responses in spontaneous and experimental animal models, including AT [110, 111] . In these models, male hormones seem to down-regulate immunity and, therefore, protect animals from autoimmunity, whereas the effect of estrogen is not always unequivocal. However, poor evidence supports a role for sex hormones in humans [110, 111] . Women with normal baseline estrogen levels, but with an increased sensitivity to the hormone, were found to have a higher prevalence of AITD [114] , although a clear-cut association between exogenous estrogen administration and GD has not been reported. In addition, thyroid autoimmunity is often found in patients with Turner's syndrome, who typically have low estrogens [115] . Conversely, male patients with primary hypogonadism such as those with Klinefelter's syndrome do not show a higher incidence of AITD [116] . In these human conditions, however, the chromosomal abnormality plays an important role that is largely independent of sex hormone levels.
Pregnancy is an important risk factor and the risk of development of GD increases four-to eightfold in the post-partum year [103] . As reported above, the abrupt fall of pregnancy-associated immune suppression that occurs immediately after delivery is likely to be the mechanism responsible. However, in a retrospective study it was found that the relative frequencies of post-partum onset of GD were similar in relation of increasing parity, which would not support a role of the post-partum period as a major risk factor for GD [117] . On the other hand, it was also shown that the post-partum period is indeed a risk factor for relapse of Graves' thyrotoxicosis after withdrawal of antithyroid drugs [118] .
In addition to sex hormones, chromosomal factors linked to the X chromosome may be responsible for the female preponderance of GD. Thus, a linkage analysis in families with GD has located a putative susceptibility locus on the long arm of the X chromosome [119] . Although most X-linked disorders are expressed phenotypically only in men, it is possible that a gene with a dose-dependent effect may determine more relevant effects in women, which could explain the higher incidence of GD in women and in patients with Turner's syndrome. Skewed inactivation of the X chromosome, an epigenetic phenomenon, has also shown to be involved in the female predisposition to GD [120, 121] . Finally, fetal microchimerism has been proposed to explain the greater prevalence of thyroid autoimmunity in general and of GD in particular in females [122] .
Smoking habits
An association between smoking and thyroid diseases, including GD has been reported by several studies [123] . Retrospective analyses indicate an increased risk of developing GD as well as of a relapse of hyperthyroidism following anti-thyroid drug withdrawal in smokers, which may be due both to a direct action of smoking metabolites on the immune system or by a damage induced by smoking metabolites on thyrocytes, thereby determining exposure of thyroid antigens to the immune system [123] .
Thyroid damage GD has been reported to appear following ethanol injections for autonomous thyroid nodules, suggesting that the thyroid damage due to ethanol may cause a massive release of thyroid antigens, thereby triggering an autoimmune response in predisposed individuals [124] . Furthermore, and possibly because of similar pathogenetic mechanisms (i.e. massive release of thyroid antigens), GD or simply serum TRAb have been reported to appear following radioiodine treatment for toxic adenoma, toxic nodular goiter [125] , and also after subacute thyroiditis [126] .
Vitamin D and selenium
Decreased levels of serum Vitamin D have been reported in patients with GD [127] and later found to be associated with a higher rate of hyperthyroidism relapse after antithyroid drug withdrawal [128] , although the mechanisms responsible for these associations remain elusive [129] . Selenium deficiency has been reported in patients with GD [130] , which could be explained by the anti-oxidant action of selenium. Thus, tissue oxidative stress is among the pathogenetic mechanisms involved in thyroid autoimmunity, including GD, and selenium supplementation has been found to be beneficial in patients with mild GO [131] .
Immune-modulating drugs and reconstitution GD GD, as well as AT or simply the development of anti-thyroid autoantibodies, can be observed following treatment with immune-modulating agents or under circumstances of lymphocyte recovery after a profound lymphopenia [132, 133] .
Among immune-modulating agents, IFNα is certainly the most studied. IFNα is a type I interferon widely used especially in C hepatitis [134] . The cytokine exerts various effects on the immune system, some of which might be implicated in the development of autoimmunity. Thus, treatment with IFNα can be followed by the appearance of anti-thyroid autoantibodies, AT, and less commonly GD (~1 % of patients given IFNα) [135] .
Alemtuzumab is an anti-CD52 monoclonal antibody used as an immune modulating agent in autoimmune conditions such as multiple sclerosis [136] . GD has been observed in up to 22 % of patients treated with alemtuzumab [136] .
As mentioned above, GD can be observed in the recovery of periods of profound immune suppression. As mentioned above, a similar phenomenon can be observed after pregnancy or treatment of Cushing's syndrome [132, 133] . Other conditions of lymphocyte reconstitutions when GD can appear are antiretroviral therapy for HIV infections or bone marrow transplantation [132, 133] .
Conclusions
Although the ultimate cause of GD remains obscure, the efforts of many investigators have shed some light on an intrigued interplay of genetic and non-genetic factors, ultimately leading to the loss of immune tolerance and to the initiation of a sustained autoimmune reaction against thyroid antigens. Hopefully the continuing technological advancements of basic research and the development of clinical, especially observational, studies will help defining a precise, though complex, picture responsible for the etiology of GD and, therefore, to establish causal treatments of such a challenging disease. Among the various aspects of GD etiology that remain to be investigated, the most suitable aims that can be achieved in the next future are, in our opinion, (1) the identification of novel genes involved; and (2) definition of the extent to which the various non-genetic factors, namely iodine, infections, stress, gender and smoking, affect the prevalence of GD in genetically susceptible versus non genetically susceptible individuals, the latter feature to be established based on the known genetic determinants and hopefully on the additional genetic determinants that will be identified in the future.
